BIOMAT Database Logo BIOMAT Database Logo

[Antiestrogen treatment in postmenopausal patients with metastatic breast cancer]. 2007

Henriette Lindberg, and Dorte Lisbet Nielsen, and Malgorzata Tuxen, and Claus Kamby
Herlev Hospital, Onkologisk Afdeling R. lindberg@dadlnet.dk

This review discusses the evidence for endocrine treatment in postmenopausal patients with metastatic breast cancer. First line treatment with non-steroid aromatase inhibitors (AI) yields response rates of 30% and improves progression free survival, but not overall survival, compared to tamoxifen. With second line treatment using steroid AI, estrogen antagonists or selective estrogen receptor modulators prolonged disease stabilisation is achieved in 40% of patients. With third line treatment using steroid AI and estrogen antagonists disease stabilisation is achieved in up to 30% of patients.

UI MeSH Term Description Entries
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077267 Fulvestrant An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer. 7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol,Faslodex,ICI 182,780,ICI 182780,ICI-182780,ZM 182780,ZM-182780,ICI182780,ZM182780
D000077289 Letrozole A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. 4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile),CGS 20267,CGS-20267,Femara,Fémara,CGS20267
D000077384 Anastrozole A nitrile and triazole derivative that acts as a selective nonsteroidal aromatase inhibitor. It is used in the treatment of ESTROGEN NUCLEAR RECEPTOR-positive breast cancer in postmenopausal women. 2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile),Anastrazole,Arimidex,ICI D1033,ZD-1033,ZD1033,Zeneca ZD 1033,ZD 1033

Related Publications

Henriette Lindberg, and Dorte Lisbet Nielsen, and Malgorzata Tuxen, and Claus Kamby
Antiestrogen treatment of postmenopausal women with primary high risk breast cancer.
January 1983, Breast cancer research and treatment,
Henriette Lindberg, and Dorte Lisbet Nielsen, and Malgorzata Tuxen, and Claus Kamby
Droloxifene, a new antiestrogen. Hormonal influences in postmenopausal breast cancer patients.
January 1991, American journal of clinical oncology,
Henriette Lindberg, and Dorte Lisbet Nielsen, and Malgorzata Tuxen, and Claus Kamby
[Experiences with Rodazol therapy in the treatment of postmenopausal patients with metastatic breast cancer].
January 1990, Zentralblatt fur Gynakologie,
Henriette Lindberg, and Dorte Lisbet Nielsen, and Malgorzata Tuxen, and Claus Kamby
Role of fulvestrant in the treatment of postmenopausal metastatic breast cancer patients.
September 2016, Expert review of clinical pharmacology,
Henriette Lindberg, and Dorte Lisbet Nielsen, and Malgorzata Tuxen, and Claus Kamby
[Everolimus plus Exemestane in Postmenopausal Metastatic Breast Cancer Patients].
October 2015, Gan to kagaku ryoho. Cancer & chemotherapy,
Henriette Lindberg, and Dorte Lisbet Nielsen, and Malgorzata Tuxen, and Claus Kamby
[Antiestrogen treatment of metastasizing breast cancer].
January 1980, Duodecim; laaketieteellinen aikakauskirja,
Henriette Lindberg, and Dorte Lisbet Nielsen, and Malgorzata Tuxen, and Claus Kamby
Droloxifene, a new antiestrogen: its role in metastatic breast cancer.
January 1994, Breast cancer research and treatment,
Henriette Lindberg, and Dorte Lisbet Nielsen, and Malgorzata Tuxen, and Claus Kamby
Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis.
July 1998, Breast cancer research and treatment,
Henriette Lindberg, and Dorte Lisbet Nielsen, and Malgorzata Tuxen, and Claus Kamby
A Novel Metastatic Estrogen Receptor-Expressing Breast Cancer Model with Antiestrogen Responsiveness.
December 2023, Cancers,
Henriette Lindberg, and Dorte Lisbet Nielsen, and Malgorzata Tuxen, and Claus Kamby
Fulvestrant: a review of its use in hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
January 2004, Drugs,
Copied contents to your clipboard!